[1]
Pongener, N. , Visi, V. and Ghatani, R. 2025. Saroglitazar for the Management of Diabetic Dyslipidemia and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. International Journal of Medical and Biomedical Studies. 9, 3 (Jun. 2025), 44–53. DOI:https://doi.org/10.32553/ijmbs.v9i3.3096.